Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Bioavailability: Influencing Factors01:22

Bioavailability: Influencing Factors

Bioavailability refers to the extent and rate at which a drug reaches systemic circulation in its active form. Extent refers to the amount of the drug that makes it into circulation, while rate is the speed at which it enters circulation. It is influenced by several factors critical for optimizing drug formulations, dosing regimens, and therapeutic outcomes.Physicochemical properties of drugs and formulationsThe solubility, stability, and dissolution rate of a drug significantly impact its...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Respiratory virus infections in decedents in a large, urban medical examiner's office.

Public health·2023
Same author

Behavioral and physiological responses to an inspired-air supplemental cooling system for dairy cows in free-stall housing.

Animal : an international journal of animal bioscience·2023
Same author

Truncation of <i>MAT1-2-7</i> Deregulates Developmental Pathways Associated with Sexual Reproduction in Huntiella omanensis.

Microbiology spectrum·2022
Same author

One key to fit all locks? Routine internal drainage to minimize seromas during thigh lift surgeries.

Annales de chirurgie plastique et esthetique·2022
Same author

Development of a novel stall design for dairy cattle: Part II. The effect of minimal stall partitioning on lying behavior, rumination, stall cleanliness, and preference.

Animal : an international journal of animal bioscience·2022
Same author

Development of a novel stall design for dairy cattle: Part I. The effect of an increased slope on lying behavior, rumination, cleanliness, and preference.

Animal : an international journal of animal bioscience·2022

相关实验视频

Updated: Jul 14, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

不同的推进剂之间的肺部生物可用性的差异,用于流他 propionate.

A M Wilson, E J Sims, L C Orr

    Lancet (London, England)
    |October 26, 1999
    PubMed
    概括

    切换流他 propionate 吸入器可能是有风险的. 新的醇化合物配方的肺部生物利用率低于旧的碳化合物配方,这可能会影响治疗的有效性.

    科学领域:

    • 药理学 药理学是指药理学的学科.
    • 呼吸系统医学 呼吸系统医学
    • 药物输送系统 药物输送系统

    背景情况:

    • 酸是广泛用于呼吸道疾病的吸入性皮质类固醇.
    • 之前的吸入器配方使用了化碳 (CFC) 作为推进剂.
    • 由于环境法规,目前的配方主要使用化 (HFA) 作为推进剂.

    研究的目的:

    • 为了比较基于CFC和HFA的吸入器配方之间的流动松 propionate的肺部生物可用性.
    • 评估这些不同类型的吸入器之间切换的临床影响.

    主要方法:

    • 通过测量上腺抑制来间接评估肺部生物可用性,这是系统吸收的酸的已知的药理动力学效应.
    • 患者或研究设计细节在摘要中没有具体说明.

    主要成果:

    • 肺部生物可用性,通过上腺抑制表明,与化碳 (CFC) 推进剂配方相比,与化 (HFA) 推进剂配方相比,化碳 (CFC) 推进剂配方的生物可用性大约是两倍.
    • 这表明,在HFA配方下,药物到达肺部的数量显著减少.

    结论:

    • 由于肺部生物可用性的显著差异,可能不建议在微克相当的基础上直接切换流动 propionate 吸入器配方.

    更多相关视频

    Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
    07:10

    Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

    Published on: May 20, 2019

    Intratracheal Administration of Dry Powder Formulation in Mice
    07:55

    Intratracheal Administration of Dry Powder Formulation in Mice

    Published on: July 25, 2020

    相关实验视频

    Last Updated: Jul 14, 2026

    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
    07:28

    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

    Published on: April 6, 2017

    Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
    07:10

    Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

    Published on: May 20, 2019

    Intratracheal Administration of Dry Powder Formulation in Mice
    07:55

    Intratracheal Administration of Dry Powder Formulation in Mice

    Published on: July 25, 2020

  • 患者和医疗保健提供者在更换吸入器类型时应该意识到潜在的治疗等价性问题.
  • 可能需要进一步的研究来确定在从CFC转换为HFA配方时进行适当的剂量调整.